相关实验视频
Updated: Jul 16, 2026

05:52
Prehospital Thrombolysis: A Manual from Berlin
Published on: November 26, 2013
在急性心肌梗塞的血小板功能治疗期间和之后,使用 reteplase,alteplase 或 streptokinase 治疗血小板功能
1Internal Medicine III (Cardiology), University of Heidelberg, Heidelberg, Germany.
Circulation
|November 5, 1999
概括
治疗急性心肌梗塞的血栓溶解剂会影响血小板聚合. 在早期阶段,与阿尔特相比,雷特和链球激酶显示出较低的血小板聚合.
科学领域:
- 心脏病学 心脏病学
- 血液学 血液学 血液学
- 药理学 药理学是指药理学的学科.
背景情况:
- 治疗急性心肌梗塞 (AMI) 的血栓解压剂可以改变血小板功能.
- 血小板聚合和受体表达的变化可能会影响再输和再封闭率.
研究的目的:
- 为了比较不同血栓消毒剂对AMI患者血小板聚合和相关标记物的影响.
- 为了评估血小板聚合,P-选择因表达和纤维素原结合在用阿尔特,网或链球酶治疗后.
主要方法:
- 分析了来自四个主要临床试验 (RAPID-1,RAPID-2,INJECT,GUSTO-3) 的126名患者的数据.
- 患者接受了多种剂量和治疗方案的阿尔特培拉斯,雷特培拉斯 (双倍或单剂量) 或链球酶.
- 测量了血小板聚合 (PA),P-选择因表达,纤维素因与GP IIb/IIIa结合,溶性P-选择因,前热血素碎片F1和F2,热血素-抗热血素复合体 (TAT) 和抗热血素III (ATIII).
主要成果:
- 与GP IIb/IIIa的PA和纤维素原结合在10+10-U reteplase或 estreptokinase治疗1小时和2小时后显著下降.
- 所有治疗组都显示F1和F2碎片和TAT水平增加,这表明血栓生成.
- 在所有血栓抑制药物治疗组中,抗血素III水平显著下降.
结论:
- 与阿尔特普拉斯相比,雷特普拉斯和链球激酶显示了更大的PA早期降低.
- 双玻尿酸整形 (10+10 U) 和链球激酶导致1小时和2小时的血压降低,而不是加速的高位.
- 与加速阿尔特等相比,Fibrinogen与GP IIb/IIIa的结合在Reteplase后的最初2小时内也较低.
相关概念视频
Formation of the Platelet Plug
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
Clot Retraction and Fibrinolysis
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Myocarditis III: Medical Management
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
Acute Coronary Syndrome IV: Interprofessional Care
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...

